Tumor Suppressor microRNA-138 Suppresses Low-Grade Glioma Development and Metastasis via Regulating IGF2BP2

Controversies in the Therapy of Low-Grade Gliomas

(2019) Ivan D. Carabenciov et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Molecular genetics and therapeutic targets of pediatric low-grade gliomas

(2019) Kensuke Tateishi et al.   Brain Tumor Pathology

Regulation of microRNA biogenesis and its crosstalk with other cellular pathways

(2018) Thomas Treiber et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Aberrant miRNA promoter methylation and EMT-involving miRNAs in breast cancer metastasis: Diagnosis and therapeutic implications

(2017) Maryam Zare et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Integrated mRNAseq and microRNAseq data analysis for grade III gliomas

(2017) Junqiang Dai et al.   Molecular Medicine Reports

C/EBPβ mediates RNA polymerase III-driven transcription of oncomiR-138 in malignant gliomas

(2017) Federica Di Pascale et al.   NUCLEIC ACIDS RESEARCH

miR-1193 Suppresses Proliferation and Invasion of Human Breast Cancer Cells Through Directly Targeting IGF2BP2

(2017) Xianglei Li et al.   ONCOLOGY RESEARCH

MiR-138-5p targeting LIMK1 suppresses breast cancer cell proliferation and motility

(2017) Dengfeng Li et al.   RSC Advances

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

(2016) David N. Louis et al.   ACTA NEUROPATHOLOGICA

IGF2BP2 promotes colorectal cancer cell proliferation and survival through interfering withRAF-1degradation by miR-195

(2016) Song Ye et al.   FEBS LETTERS

Current and future strategies for treatment of glioma

(2016) Nancy Ann Oberheim Bush et al.   NEUROSURGICAL REVIEW

Unknown

(2016)   Oncotarget

MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints

(2015) Jun Wei et al.   NEURO-ONCOLOGY

Effects of IGF2BP2, KCNQ1 and GCKR polymorphisms on clinical outcome in metastatic gastric cancer treated with EOF regimen

(2015) Xin Liu et al.   PHARMACOGENOMICS

miR-138-5p reverses gefitinib resistance in non-small cell lung cancer cells via negatively regulating G protein-coupled receptor 124

(2014) Yi Gao et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Suppression of tumorigenicity by MicroRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme

(2013) Shuwei Qiu et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Oncogenic NRAS, Required for Pathogenesis of Embryonic Rhabdomyosarcoma, Relies upon the HMGA2-IGF2BP2 Pathway

(2013) Z. Li et al.   CANCER RESEARCH

MiR-138 Inhibits Tumor Growth Through Repression of EZH2 in Non-Small Cell Lung Cancer

(2013) Huijun Zhang et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Down-regulation of miR-138 promotes colorectal cancer metastasis via directly targeting TWIST2

(2013) Limin Long et al.   Journal of Translational Medicine

MicroRNA-200b targets CREB1 and suppresses cell growth in human malignant glioma

(2013) Biao Peng et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer

(2012) Paul Lochhead et al.   EUROPEAN JOURNAL OF CANCER

Targeting Glioma Stem Cells by Functional Inhibition of a Prosurvival OncomiR-138 in Malignant Gliomas

(2012) Xin Hui Derryn Chan et al.   Cell Reports

microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs

(2009) Hongping Xia et al.   BRAIN RESEARCH

A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis

(2009) Gabriele Siegel et al.   NATURE CELL BIOLOGY

Targeting of the Bmi-1 Oncogene/Stem Cell Renewal Factor by MicroRNA-128 Inhibits Glioma Proliferation and Self-Renewal

(2008) J. Godlewski et al.   CANCER RESEARCH